Login Register
icon_bulk_orderBulk order Acrobiosystems for English
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9

Recombinant Proteins & Antibodies

SARS-CoV-2 Mutants

Emerging VoCs, Omicron, Delta, Beta, Alpha mutants and so on, including RBD, S trimer, S1, NTD, NP, etc. These mutants are of high purity and bioactivity and can be used to evaluate the efficacy of the antibodies and vaccination.

GMP Grade Cytokines

ACROBiosystems developed a series of GMP grade cytokines under the GMP grade quality management system. Those products are all suitable for T/NK cell generation, activation, and proliferation in cell therapy research.

Targets of CAR-T Cell Therapy

50+ targets designed for CAR detection, including PE/FITC/biotin labeled proteins. The key reagents for CD19 and BCMA were FDA DMF filed which can support your IND, NDA and BLA process.                  

Discovery Solutions for CGT

GMP grade cytokines, reagents for cell activation, gene edition, DNA/RNA removal, etc. Particularly focus on product design, quality control and solution-based support to link each phase of your cell and gene therapy journey.

Full-length Transmembrane Proteins

Full length multi-pass TPs with stabilized structure and high bioactivity for immunization, antibody screening, cell based assay and CAR detection, including hot CD20, Claudin 18.2, CD133, GPRC5D,CCR8, CCR5, etc.

BsAb targets

CD3 proteins and a collection of for bispecific antibody development which are of high specificity and bioactivities and suitable for immunization, antibody screening.

Immune Checkpoints

A series of immune checkpoints including classic co-inhibitory and co-stimulatory receptors. The comprehensive catalog contains 100+ targets with various species and tags, and the high-quality proteins are in good batch-to-batch consistency.

Targets for ADCs

To meet the needs of ADCs development, ACROBiosystems can provide: A variety of high-quality target proteins; MMPs/Cathepsin/uPA for cleavable linker; Anti-payload antibodies & anti-idiotypic antibodies for immunogenicity and PK analysis; SPR/BLI analytical and ADA development service.

Fc Receptors

Comprehensive collection of Fc receptor proteins, including their common variants, which can help expedite your antibody development.

MABSOL® Biotinylated Proteins

The MABSOL biotinylated protein collection includes more than a hundred commonly studied drug targets and biomarker proteins.

Cytokines

Comprehensive cytokines including IL families, growth factors, chemokines, TNFs, etc. These products are HEK293 expressed and nearly in authentic structure, high purity and bioactivity, cell based assay/SPR/BLI verified.

Anti-idiotypic Antibodies

To support preclinical/clinical immunogenicity and PK analysis, ACROBiosystems has developed a series of high-affinity anti-idiotypic antibodies. Our pipeline covers five hot targets including adalimum*b, rituxim*b, cetuxim*b, trastuzum*b, and bevacizum*b.

Newly Added Products

Mutants from SARS-CoV-2 Emerging Variants Omicron and more

ACROBiosystems are going full steam ahead on developing a collection of recombinant antigens for emergency SARS-CoV-2 variants. The reagents can be used to evaluate the efficacy of the antibodies and vaccination.

GMP Grade Cytokines

ACROBiosystems developed a series of GMP grade cytokines under the GMP grade quality management system. Those products are all suitable for T/NK cell generation, activation, and proliferation in cell therapy research.

News Center

Variant Boosters, Bivalent and Polyvalent Vaccines… Who’s Going to Break the Stalemate with COVID-19?
2022/08/09
Variant Boosters, Bivalent and Polyvalent Vaccines… Who’s Going to Break the Stalemate with COVID-19?
In response to the continuously evolving situation regarding COVID-19 and its variants, ACROBiosystems is committed to continuously updating our series of core reagents to offer a comprehensive solution for both mutant-based and bivalent vaccines.
Learn more
ACROBiosystems announces the release of their latest BA.2.75 antigen products
2022/08/05
ACROBiosystems announces the release of their latest BA.2.75 antigen products
Last week, ACROBiosystems announced their latest antigen products targeting BA.2.75 for satisfying current Covid-19 vaccine strategy.
Learn more
ViruStop, ACROBiosystems’s new brand accelerating the process of vaccine development and approval
2022/06/22
ViruStop, ACROBiosystems’s new brand accelerating the process of vaccine development and approval
Bringing together core R&D tools for rabies, influenza, shingles, Ebola, Zika and other viruses, providing high quality antigens, antibodies, ELISA kits, etc., ACROBiosystems is willing to work together with biopharmaceutical companies, blocking the spread of viruses, Stop Viruses!
Learn more
Cell-to-Cell Communication in Cancer
2022/08/25 - 2022/08/25
Cell-to-Cell Communication in Cancer
Speaker: Marina K. Holz, Ph.D.
Time: August 25, 2022, Thursday,8am PDT | 11am EDT | 4pm BST | 5pm CEST
Learn more

This web search service is supported by Google Inc.

totop
Call us
Call us
North America: +1 800-810-0816 (Toll Free)
Asia & Pacific: +86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message